EcoDrugPlus

Ensembl ID : ML320915a
Gene Symbol: -
External references: -
69 Possible Orthologues:

Ensembl ID : ML320916a
Gene Symbol: -
External references: -
69 Possible Orthologues:

Ensembl ID : ML320917a
Gene Symbol: -
External references: -
89 Possible Orthologues:

Ensembl ID : ML32096a
Gene Symbol: -
External references: -
244 Possible Orthologues:

Ensembl ID : ML32097a
Gene Symbol: -
External references: -
244 Possible Orthologues:

Ensembl ID : ML32742a
Gene Symbol: -
External references: -
146 Possible Orthologues:

Ensembl ID : ML33723a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML342210a
Gene Symbol: -
External references: -
246 Possible Orthologues:

Ensembl ID : ML34223a
Gene Symbol: -
External references: -
86 Possible Orthologues:

Ensembl ID : ML343410a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML343411a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML343418a
Gene Symbol: -
External references: -
137 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).